Fact CheckerSign in

NCT06896370Recruiting

An Observational Study for Gastric Cancer in Carriers of High Risk Helicobacter Pylori

Risk of Gastric Cancer in High-risk Carriers of Helicobacter Pylori: an Observational Cohort Study

Source: ClinicalTrials.gov · Last updated 25 Feb 2026

Brief summary (registry, in English)

This study is intended to be a prospective observational cohort study. The incidence of gastric cancer and progression of gastric precancerous lesions will be compared between groups through prospective follow-up of a population with baseline negative gastric endoscopy, harboring high-risk Hp SNP subtypes and non-high-risk subtypes.

Status (registry)
Recruiting
Study type
Observational
Enrollment
3000 (estimated)
First submitted
20 Mar 2025
Start date
1 Jul 2025
Primary completion date
1 May 2035
Lead sponsor
Fudan University
NCT number
NCT06896370

What you commit to

  • Study type: Observational
  • Planned participants: 3000
  • From 1 Jul 2025 to the primary completion date, 1 May 2035
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • A history of diagnosed gastric cancer or other malignant tumors of the digestive tract.
  • Comorbid severe underlying conditions (e.g., severe cardiopulmonary insufficiency, liver or renal failure, etc.) that are likely to result in a short life expectancy or render long-term follow-up impractical.
  • Severe mental illness or incapacity to participate in the study due to lack of civil behavior.
  • Other conditions that the investigator deems inappropriate for participation in the study.

Other

  • Pregnant or breastfeeding women.

Who the study is looking for

  • Age ≥ 40 years, gender is not limited.
  • Able and willing to provide informed consent and willing to undergo baseline and follow-up examinations.

Age in the registry: 40 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
People's Hospital of Tongling City
Coordinator of this site? Confirm its status
TonglingChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.